Primus In News
Indian CDMOs get a growth pill
28-01-2026
Nilaya Varma, Group CEO and Co-Founder, Primus Partners, shared his view that the free trade agreement would open access to Europe’s pharmaceutical and medical devices market, valued at around $572 billion, while strengthening India’s position as a global manufacturing hub.
Explore Related Insights
- Founders and investors reveal the do’s and don’ts of D2C brand building at Rajasthan IT Day 2025
- Mimicking the brain! Why neuromorphic computing can redefine the IoT
- Union Budget may tweak customs duties, ensure ease of import compliance
- Smallcap index snaps 5-day losses but analysts say it will continue to underperform: Here are four reasons why
